These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 31340883

  • 1. Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
    Cybulska P, Paula ADC, Tseng J, Leitao MM, Bashashati A, Huntsman DG, Nazeran TM, Aghajanian C, Abu-Rustum NR, DeLair DF, Shah SP, Weigelt B.
    Gynecol Oncol; 2019 Sep; 154(3):516-523. PubMed ID: 31340883
    [Abstract] [Full Text] [Related]

  • 2. Massively Parallel Sequencing-Based Clonality Analysis of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
    Schultheis AM, Ng CK, De Filippo MR, Piscuoglio S, Macedo GS, Gatius S, Perez Mies B, Soslow RA, Lim RS, Viale A, Huberman KH, Palacios JC, Reis-Filho JS, Matias-Guiu X, Weigelt B.
    J Natl Cancer Inst; 2016 Jun; 108(6):djv427. PubMed ID: 26832770
    [Abstract] [Full Text] [Related]

  • 3. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M, Zimmermann AK, Wild PJ, Caduff R, von Teichman A, Fink D, Moch H, Noske A.
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [Abstract] [Full Text] [Related]

  • 4. PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas.
    Marchiò C, De Filippo MR, Ng CK, Piscuoglio S, Soslow RA, Reis-Filho JS, Weigelt B.
    Gynecol Oncol; 2015 May; 137(2):321-8. PubMed ID: 25701704
    [Abstract] [Full Text] [Related]

  • 5. Use of mutation profiles to refine the classification of endometrial carcinomas.
    McConechy MK, Ding J, Cheang MC, Wiegand K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T, McDonald H, Schmidt AP, Mutch DG, McAlpine JN, Hirst M, Shah SP, Lee CH, Goodfellow PJ, Gilks CB, Huntsman DG.
    J Pathol; 2012 Sep; 228(1):20-30. PubMed ID: 22653804
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J, Ren F, Filali-Mouhim A, Sanchez L, Köbel M, Tonin PN, Huntsman D, Provencher DM, Mes-Masson AM.
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [Abstract] [Full Text] [Related]

  • 7. An integrated molecular profile of endometrioid ovarian cancer.
    Pierson WE, Peters PN, Chang MT, Chen LM, Quigley DA, Ashworth A, Chapman JS.
    Gynecol Oncol; 2020 Apr; 157(1):55-61. PubMed ID: 32139151
    [Abstract] [Full Text] [Related]

  • 8. Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas.
    Coenegrachts L, Garcia-Dios DA, Depreeuw J, Santacana M, Gatius S, Zikan M, Moerman P, Verbist L, Lambrechts D, Matias-Guiu X, Amant F.
    Virchows Arch; 2015 Apr; 466(4):415-22. PubMed ID: 25677978
    [Abstract] [Full Text] [Related]

  • 9. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM, Martelotto LG, De Filippo MR, Piscuglio S, Ng CK, Hussein YR, Reis-Filho JS, Soslow RA, Weigelt B.
    Int J Gynecol Pathol; 2016 Jul; 35(4):289-300. PubMed ID: 26556035
    [Abstract] [Full Text] [Related]

  • 10. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.
    Hussein YR, Weigelt B, Levine DA, Schoolmeester JK, Dao LN, Balzer BL, Liles G, Karlan B, Köbel M, Lee CH, Soslow RA.
    Mod Pathol; 2015 Apr; 28(4):505-14. PubMed ID: 25394778
    [Abstract] [Full Text] [Related]

  • 11. Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
    Leskela S, Romero I, Rosa-Rosa JM, Caniego-Casas T, Cristobal E, Pérez-Mies B, Gutierrez-Pecharroman A, Santón A, Ojeda B, López-Reig R, Palacios-Berraquero ML, Andrada E, Montes S, Pastor F, Gomez MC, López-Guerrero JA, Poveda A, Palacios J.
    Am J Surg Pathol; 2020 Jul; 44(7):982-990. PubMed ID: 32384322
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetic alterations and their therapeutic implications in epithelial ovarian cancer.
    Lapke N, Chen CH, Chang TC, Chao A, Lu YJ, Lai CH, Tan KT, Chen HC, Lu HY, Chen SJ.
    BMC Cancer; 2021 May 04; 21(1):499. PubMed ID: 33947352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.